Abstract
Demand and deliver: Micelles reversibly crosslinked by boronate esters (see scheme) show in vitro and in vivo stability, and thus minimize premature drug release under physiological conditions. After reaching the tumor sites, drug (stars in scheme) release is activated by cleavage of the boronate esters by the acidic conditions around the tumor or in the target cells, or by the administration of mannitol.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2864-2869 |
| Number of pages | 6 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 51 |
| Issue number | 12 |
| DOIs | |
| State | Published - Mar 19 2012 |
Keywords
- boronate
- controlled release
- FRET
- micelles
- nanocarriers
ASJC Scopus subject areas
- Chemistry(all)
- Catalysis
Fingerprint Dive into the research topics of 'Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols'. Together they form a unique fingerprint.
Cite this
Li, Y., Xiao, W., Xiao, K., Berti, L., Luo, J. T., Tseng, H. P., Fung, G., & Lam, K. S. (2012). Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. Angewandte Chemie - International Edition, 51(12), 2864-2869. https://doi.org/10.1002/anie.201107144